Gloucestershire Health and Care- NHS Trust logo
with you, for you
Clinical Activity Data > Anabolic Steroid Related Hospital Admissions

Freedom of Information request Anabolic Steroid Related Hospital Admissions

Response published: 18 June 2026

FOI Request

Dear Freedom of Information Team, Under the Freedom of Information Act 2000, I would like to request the following information for each financial year from 2021/22 to 2025/26 (or the most recent five complete years available). Please provide: 1. The number of hospital admissions where anabolic-androgenic steroid (AAS) use, misuse, dependence, poisoning, adverse effects, complications, or abuse was recorded as: a) the primary diagnosis; and/or b) a secondary diagnosis. 2. The number of inpatient deaths where anabolic-androgenic steroid use, misuse, dependence, poisoning, adverse effects, complications, or abuse was recorded anywhere within the patient's diagnostic record. 3. The number of admissions involving: a) acute liver failure; b) chronic liver disease; c) cirrhosis; d) drug-induced liver injury; where anabolic-androgenic steroid use, misuse, dependence, poisoning, adverse effects, complications, or abuse was also recorded. 4. Any ICD-10 codes, SNOMED codes, or other clinical coding definitions used by the Trust to identify the cases included in response to Questions 1–3. 5. If available, please provide annual totals broken down by: a) age group (under 18, 18–24, 25–34, 35–44, 45–54, 55+); and b) sex. If the Trust does not specifically record anabolic-androgenic steroid use, please provide any equivalent data held relating to anabolic steroid misuse or abuse and explain the coding methodology used. If any part of this request exceeds the cost limit, please provide advice and assistance under Section 16 of the Freedom of Information Act to help refine the request. I would prefer the information in electronic spreadsheet format (Excel or CSV). Yours faithfully,

FOI Response

Freedom of Information Request – Ref: FOI 172-2026

Thank you for your recent Freedom of Information request. Please find our response below.

You asked:

1. The number of hospital admissions where anabolic-androgenic steroid (AAS) use, misuse, dependence, poisoning, adverse effects, complications, or abuse was recorded as:

a) the primary diagnosis; and/or
b) a secondary diagnosis.

2. The number of inpatient deaths where anabolic-androgenic steroid use, misuse, dependence, poisoning, adverse effects, complications, or abuse was recorded anywhere within the patient’s diagnostic record.

3. The number of admissions involving:

a) acute liver failure;
b) chronic liver disease;
c) cirrhosis;
d) drug-induced liver injury;
where anabolic-androgenic steroid use, misuse, dependence, poisoning, adverse effects, complications, or abuse was also recorded.

4. Any ICD-10 codes, SNOMED codes, or other clinical coding definitions used by the Trust to identify the cases included in response to Questions 1–3.

5. If available, please provide annual totals broken down by:

a) age group (under 18, 18–24, 25–34, 35–44, 45–54, 55+); and
b) sex.

Our response:

Our Trust does not hold the information requested.  Patients admitted to hospital where anabolic-androgenic steroid (AAS) use, misuse, dependence, poisoning, adverse effects, complications, or abuse to the best of our knowledge would be admitted to and recorded by Gloucestershire Hospitals NHS Foundation Trust.  You may wish to re-direct your request to Gloucestershire Hospitals NHS Foundation Trust at ghn-tr.foi@nhs.net.

Next steps:

Should you have any queries in relation to our response, please do not hesitate to contact us. If you are unhappy with the response you have received in relation to your request and wish to ask us to review our response, you should write to:

Louise Moss
Head of Legal Services / Associate Director of Corporate Governance
c/o Gloucestershire Health and Care NHS Foundation Trust
Edward Jenner Court
1010 Pioneer Avenue
Gloucester Business Park
Brockworth, GL3 4AW
E-mail: louise.moss@ghc.nhs.uk

If you are not content with the outcome of any review, you may apply directly to the Information Commissioner’s Office (ICO) for further advice/guidance. Generally, the ICO will not consider your case unless you have exhausted your enquiries with the Trust which should include considering the use of the Trust’s formal complaints procedure. The ICO can be contacted at: The Information Commissioner’s Office, Wycliffe House, Water Lane, Wilmslow, Cheshire SK9 5AF.